Breast cancer Clinical Trials in Edgewood, KY
As of June 2026, 7 paid clinical trials are recruiting for Breast cancer in Edgewood, Kentucky. Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Related specialties in Edgewood
Filter results
7 clinical trials for Breast cancer
·Clear filters·↓ Download CSVA Phase 1 Study of LNCB74 in Advanced Solid Tumors
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
About research studies in Edgewood
Edgewood has approximately 55 recruiting research studies across a wide range of therapeutic areas. Kentucky hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Top Research Study Locations in Edgewood
Researchers run research studies in Edgewood, KY at 21 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| St. Elizabeth Healthcare | Heart Failure, Solid Tumor, Acute Myocardial Infarction | 14 |
| Saint Elizabeth Healthcare Edgewood | Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adenocarcinoma of the Colon | 7 |
| Saint Elizabeth Medical Center Edgewood | Breast Neoplasms, Chronic Lymphocytic Leukemia, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer | 7 |
| Saint Elizabeth Healthcare | Coronary Artery Disease, Tachyarrhythmia, Chronic Lymphocytic Leukemia | 4 |
| Saint Elizabeth Medical Center Edgewood-Cancer Care Center | Triple-Negative Breast Cancer, Breast Neoplasms, Non Small Cell Lung Cancer | 3 |
| St Elizabeth Healthcare | Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), Prostatic Neoplasms, Castration-Resistant, Somatostatin Receptor Positive (SSTR+) | 2 |
| St. Elizabeth Healthcare - Edgewood | Advanced Melanoma, Deep Vein Thrombosis (DVT), Thrombus in the Central and Peripheral Circulatory System, Including Saphenous Vein Grafts | 2 |
| Clinical Study Site | Metastatic Colorectal Cancer (CRC) | 1 |
| Iqra Research | Degenerative Disc Disease | 1 |
| Local Institution - 0366 | Carcinoma, Non-Small-Cell Lung | 1 |
| Saint Elizabeth Medical Center | Acute Myocardial Infarction (AMI), Cardiovascular Risk | 1 |
| Saint Elizabeth Medical Center, Inc. DBA St. Elizabeth Health Care | Metastatic Pancreatic Adenocarcinoma, Metastatic Pancreatic Cancer, Pancreatic Cancer | 1 |
| St Elizabeth Health Care - CRI | Diabetes Mellitus, Type 2, Metabolic Syndrome, PreDiabetes | 1 |
| St Elizabeth Healthcare (St Elizabeth Medical | Advanced Melanoma | 1 |
| St Elizabeth Healthcare (St Elizabeth Medical Center) | Advanced Melanoma | 1 |
| St. Elizabeth - Edgewood | Lumbar Spinal Stenosis | 1 |
| St. Elizabeth Edgewood | Deep Venous Thrombosis, Post-Thrombotic Syndrome, Venous Thromboembolism | 1 |
| St. Elizabeth Edgewood Hospital | Breast Cancer | 1 |
| St. Elizabeth Health | Atrial Fibrillation, Stroke | 1 |
| St. Elizabeth Medical Center | Solid Cancer | 1 |
| St. Elizabeth Medical Center - Edgewood | Advanced High-Grade Epithelial Ovarian Cancer, Fallopian Tube Cancers, Primary Peritoneal Cancer | 1 |
Active & Upcoming Studies in Edgewood (2026)
Recruiting trials in Edgewood grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (32 active studies)
- A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma · Phase 2 · Regeneron Pharmaceuticals
- A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer · Phase 3 · Astellas Pharma Global Development, Inc.
Cardiovascular (8 active studies)
- Computerized Decision Support to Prevent Stroke in Atrial Fibrillation · Brigham and Women's Hospital
- ELEVATE High-Risk PCI Pivotal Study · Magenta Medical Ltd.
Diabetes & metabolic (2 active studies)
- Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D) · Phase 2 · Sparrow Pharmaceuticals
- A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events · Cleerly, Inc.
Neurology & pain (1 active study)
- Computerized Decision Support to Prevent Stroke in Atrial Fibrillation · Brigham and Women's Hospital
Pediatric (1 active study)
- Target Trial Emulation for Pharmacologic Treatment of Neonatal Opioid Withdrawal Syndrome · HELP for NOWS Consortium
Common conditions studied in Edgewood
- Breast Cancer (3 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Breast Neoplasms (3 active studies). Recruiting Breast Neoplasms studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Chronic Lymphocytic Leukemia (3 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Heart Failure (3 active studies). Heart failure trials explore SGLT-2 inhibitors, novel myosin modulators, and device-based therapies for both reduced and preserved ejection fraction.
- Advanced Melanoma (2 active studies). Melanoma trials test immune checkpoint inhibitors, adoptive cell therapies, and BRAF/MEK targeted combinations in both early and metastatic disease.
- Coronary Artery Disease (2 active studies). Coronary artery disease research evaluates lipid-lowering therapies, anti-inflammatory agents, and new revascularization devices.
Leading research sponsors in Edgewood
- Merck Sharp & Dohme LLC
- Medtronic
- Alliance for Clinical Trials in Oncology
- Astellas Pharma Global Development, Inc.
- Immunocore Ltd
Local regulations and guidelines
Clinical trials in Kentucky are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Kentucky research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Edgewood. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Edgewood
Hipa.ai aggregates every recruiting study in Edgewood from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Edgewood?
There are approximately 55 recruiting clinical trials in Edgewood, Kentucky listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Edgewood pay participants?
Most recruiting trials in Edgewood compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Edgewood?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Edgewood?
The most common conditions under active study in Edgewood include Breast Cancer (3), Breast Neoplasms (3), Chronic Lymphocytic Leukemia (3), Heart Failure (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Edgewood?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Edgewood on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Edgewood?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Edgewood?
Recruiting research sites in Edgewood include St. Elizabeth Healthcare, Saint Elizabeth Healthcare Edgewood, Saint Elizabeth Medical Center Edgewood, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Edgewood right now?
The largest active categories in Edgewood are Cancer & tumors (32), Cardiovascular (8), Diabetes & metabolic (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.